Stay updated on FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    An updated site revision entry, v3.6.5, has been added, replacing the previous v3.6.4 in the revision history. This reflects a deployment or platform update rather than changes to the study data.
    Difference
    0.0%
    Check dated 2026-08-10T10:44:47.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now displays an updated site revision to v3.6.4, signaling a software patch applied to the ClinicalTrials.gov interface. This update represents an interface-level change rather than a modification to the study data.
    Difference
    0.0%
    Check dated 2026-07-27T06:22:48.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.3, replacing v3.6.2, indicating a minor UI/version update to the page rendering. It does not modify the study data or how the page operates.
    Difference
    0.0%
    Check dated 2026-07-05T13:47:18.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2 on the page, reflecting a minor version update to the site's rendering or functionality. This update does not alter study details or other visible content.
    Difference
    0.0%
    Check dated 2026-06-28T08:22:33.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment-status note; it also reflects a header labeling change for Intervention/Treatment and a version update to Revision: v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-14T03:28:43.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a minor update to the page metadata.
    Difference
    0.0%
    Check dated 2026-06-06T23:39:21.000Z thumbnail image

Stay in the know with updates to FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.